Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


Articles published in J Neurosci

Retrieve available abstracts of 40 articles:
HTML format



Single Articles


    November 2022
  1. ADAMS JN, Kim S, Rizvi B, Sathishkumar M, et al
    Entorhinal-Hippocampal Circuit Integrity Is Related to Mnemonic Discrimination and Amyloid-beta Pathology in Older Adults.
    J Neurosci. 2022;42:8742-8753.
    PubMed     Abstract available


  2. NASSIF C, Kawles A, Ayala I, Minogue G, et al
    Integrity of Neuronal Size in the Entorhinal Cortex Is a Biological Substrate of Exceptional Cognitive Aging.
    J Neurosci. 2022;42:8587-8594.
    PubMed     Abstract available


    August 2022
  3. MUMFORD P, Tosh J, Anderle S, Gkanatsiou Wikberg E, et al
    Genetic Mapping of APP and Amyloid-beta Biology Modulation by Trisomy 21.
    J Neurosci. 2022;42:6453-6468.
    PubMed     Abstract available


  4. GUO T, Pan X, Jiang G, Zhang D, et al
    Downregulating PTBP1 fails to convert astrocytes into hippocampal neurons and to alleviate symptoms in Alzheimer's mouse models.
    J Neurosci. 2022 Aug 9. pii: JNEUROSCI.1060-22.2022.
    PubMed     Abstract available


  5. WALSH C, Ridler T, Margetts-Smith G, Garcia Garrido M, et al
    Beta bursting in the retrosplenial cortex is a neurophysiological correlate of environmental novelty which is disrupted in a mouse model of Alzheimer's disease.
    J Neurosci. 2022 Aug 4. pii: JNEUROSCI.0890-21.2022.
    PubMed     Abstract available


  6. BAIER MP, Nagaraja RY, Yarbrough HP, Owen DB, et al
    Selective Ablation of Sod2 in Astrocytes Induces Sex-Specific Effects on Cognitive Function, d-Serine Availability, and Astrogliosis.
    J Neurosci. 2022;42:5992-6006.
    PubMed     Abstract available


  7. CAI C, Wang L, Li S, Lou S, et al
    Ras Inhibitor Lonafarnib Rescues Structural and Functional Impairments of Synapses of Abeta1-42 Mice via alpha7nAChR-Dependent BDNF Upregulation.
    J Neurosci. 2022;42:6090-6107.
    PubMed     Abstract available


    July 2022
  8. WANG S, Fu Y, Miyata T, Matsumoto S, et al
    Functional cooperation of alpha-synuclein and tau is essential for proper corticogenesis.
    J Neurosci. 2022 Jul 29. pii: JNEUROSCI.0396-22.2022.
    PubMed     Abstract available


  9. BOLD CS, Baltissen D, Ludewig S, Back MK, et al
    APPsalpha Rescues Tau-Induced Synaptic Pathology.
    J Neurosci. 2022;42:5782-5802.
    PubMed     Abstract available


    June 2022
  10. WANG LH, Lin CY, Lin YM, Buee L, et al
    Calpain-2 Mediates MBNL2 Degradation and a Developmental RNA Processing Program in Neurodegeneration.
    J Neurosci. 2022;42:5102-5114.
    PubMed     Abstract available


  11. SHI Q, Chang C, Saliba A, Bhat MA, et al
    Microglial mTOR Activation Upregulates Trem2 and Enhances beta-Amyloid Plaque Clearance in the 5XFAD Alzheimer's Disease Model.
    J Neurosci. 2022 Jun 2. pii: JNEUROSCI.2427-21.2022.
    PubMed     Abstract available


    May 2022

  12. Erratum: Larson et al., "Soluble alpha-Synuclein Is a Novel Modulator of Alzheimer's Disease Pathophysiology".
    J Neurosci. 2022 May 26. pii: JNEUROSCI.0896-22.2022.
    PubMed    


  13. TU G, Halawa A, Yu X, Gillman S, et al
    Outcome-Locked Cholinergic Signaling Suppresses Prefrontal Encoding of Stimulus Associations.
    J Neurosci. 2022;42:4202-4214.
    PubMed     Abstract available


    April 2022
  14. DE OLIVEIRA P, Cella C, Locker N, Ravindran KKG, et al
    Improved Sleep, Memory, and Cellular Pathological Features of Tauopathy, Including the NLRP3 Inflammasome, after Chronic Administration of Trazodone in rTg4510 Mice.
    J Neurosci. 2022;42:3494-3509.
    PubMed     Abstract available


    January 2022

  15. Erratum: Takamura et al., "Modality-Specific Impairment of Hippocampal CA1 Neurons of Alzheimer's Disease Model Mice".
    J Neurosci. 2022 Jan 27. pii: JNEUROSCI.2522-21.2021.
    PubMed    


  16. DE FLORES R, Das SR, Xie L, Wisse LEM, et al
    Medial temporal lobe networks in Alzheimer's disease: structural and molecular vulnerabilities.
    J Neurosci. 2022 Jan 26. pii: JNEUROSCI.0949-21.2021.
    PubMed     Abstract available


  17. KOCAGONCU E, Nesbitt D, Emery T, Hughes L, et al
    Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease.
    J Neurosci. 2022 Jan 10. pii: JNEUROSCI.0697-21.2021.
    PubMed     Abstract available


  18. ISLAM S, Sun Y, Gao Y, Nakamura T, et al
    Presenilin is essential for ApoE secretion, a novel role of presenilin involved in Alzheimer's disease pathogenesis.
    J Neurosci. 2022 Jan 5. pii: JNEUROSCI.2039-21.2021.
    PubMed     Abstract available


    December 2021

  19. Expression of Concern: Wang et al., "Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A".
    J Neurosci. 2021 Dec 17. pii: JNEUROSCI.2306-21.2021.
    PubMed    



  20. Expression of Concern: Wang et al., "Dissociating beta-Amyloid from alpha7 Nicotinic Acetylcholine Receptor by a Novel Therapeutic Agent, S 24795, Normalizes alpha7 Nicotinic Acetylcholine and NMDA Receptor Function in Alzheimer's Disease Brain".
    J Neurosci. 2021 Dec 17. pii: JNEUROSCI.2307-21.2021.
    PubMed    


  21. CUI J, Ait-Ghezala G, Sambamurti K, Gao F, et al
    Sex-specific regulation of beta-Secretase: a novel estrogen response element (ERE)-dependent mechanism in Alzheimer's disease.
    J Neurosci. 2021 Dec 9. pii: JNEUROSCI.0864-20.2021.
    PubMed     Abstract available


  22. CHAVES RS, Tran M, Holder AR, Balcer AM, et al
    Amyloidogenic Processing of Amyloid Precursor Protein Drives Stretch-Induced Disruption of Axonal Transport in hiPSC-Derived Neurons.
    J Neurosci. 2021;41:10034-10053.
    PubMed     Abstract available


    November 2021

  23. Erratum: Medeiros et al., "Connecting TNF-alpha Signaling Pathways to iNOS Expression in a Mouse Model of Alzheimer's Disease: Relevance for the Behavioral and Synaptic Deficits Induced by Amyloid beta Protein".
    J Neurosci. 2021 Nov 17. pii: JNEUROSCI.2000-21.2021.
    PubMed    



  24. Erratum: Wang et al., "Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A".
    J Neurosci. 2021 Nov 10. pii: JNEUROSCI.2154-21.2021.
    PubMed    


    August 2021
  25. WU M, Liu CZ, Barrall EA, Rissman RA, et al
    Unbalanced regulation of alpha7 nAChRs by Ly6h and NACHO contributes to neurotoxicity in Alzheimer's disease.
    J Neurosci. 2021 Aug 26. pii: JNEUROSCI.0494-21.2021.
    PubMed     Abstract available


    May 2021
  26. OAKLEY DH, Klickstein N, Commins C, Chung M, et al
    Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
    J Neurosci. 2021;41:4335-4348.
    PubMed     Abstract available


  27. SALAMONE PC, Legaz A, Sedeno L, Moguilner S, et al
    Interoception Primes Emotional Processing: Multimodal Evidence from Neurodegeneration.
    J Neurosci. 2021;41:4276-4292.
    PubMed     Abstract available


  28. TAKAMURA R, Mizuta K, Sekine Y, Islam T, et al
    Modality specific impairment of hippocampal CA1 neurons of Alzheimer's disease model mice.
    J Neurosci. 2021 May 10. pii: JNEUROSCI.0208-21.2021.
    PubMed     Abstract available


  29. GOODMAN AM, Langner BM, Jackson N, Alex C, et al
    Heightened hippocampal beta-adrenergic receptor function drives synaptic potentiation and supports learning and memory in the TgF344-AD rat model during prodromal Alzheimer's disease.
    J Neurosci. 2021 May 5. pii: JNEUROSCI.0119-21.2021.
    PubMed     Abstract available


    April 2021
  30. ADAMS JN, Maass A, Berron D, Harrison TM, et al
    Reduced Repetition Suppression in Aging is Driven by Tau-Related Hyperactivity in Medial Temporal Lobe.
    J Neurosci. 2021;41:3917-3931.
    PubMed     Abstract available


  31. VAN SKIKE CE, Hussong SA, Hernandez SF, Banh AQ, et al
    mTOR attenuation with rapamycin reverses neurovascular uncoupling and memory deficits in mice modeling Alzheimer's disease.
    J Neurosci. 2021 Apr 20. pii: JNEUROSCI.2144-20.2021.
    PubMed     Abstract available


    March 2021
  32. MORENO-JIMENEZ EP, Terreros-Roncal J, Flor-Garcia M, Rabano A, et al
    Evidences for Adult Hippocampal Neurogenesis in Humans.
    J Neurosci. 2021;41:2541-2553.
    PubMed     Abstract available


    February 2021
  33. SANCHEZ-AGUILERA A, Quintanilla JP
    Sharp Wave Ripples in Alzheimer's Disease: In Search of Mechanisms.
    J Neurosci. 2021;41:1366-1370.
    PubMed    


  34. RIVERS-AUTY J, Tapia VS, White CS, Daniels MJ, et al
    Zinc status alters Alzheimer's disease progression through NLRP3-dependent inflammation.
    J Neurosci. 2021 Feb 16. pii: JNEUROSCI.1980-20.2020.
    PubMed     Abstract available


    November 2020
  35. FRACASSI A, Marcatti M, Zolochevska O, Tabor N, et al
    Oxidative damage and antioxidant response in frontal cortex of demented and non-demented individuals with Alzheimer's neuropathology.
    J Neurosci. 2020 Nov 24. pii: JNEUROSCI.0295-20.2020.
    PubMed     Abstract available


    October 2020
  36. ALBRECHT D, Isenberg AL, Stradford J, Monreal T, et al
    Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid.
    J Neurosci. 2020;40:8573-8586.
    PubMed     Abstract available



  37. Erratum: Forny-Germano et al., "Alzheimer's Disease-Like Pathology Induced by Amyloid-beta Oligomers in Nonhuman Primates".
    J Neurosci. 2020 Oct 6. pii: JNEUROSCI.1827-20.2020.
    PubMed    


    September 2020
  38. CHEN W, Wang M, Zhu M, Xiong W, et al
    14,15-epoxyeicosatrienoic acid alleviates pathology in a mouse model of Alzheimer's disease.
    J Neurosci. 2020 Sep 24. pii: JNEUROSCI.1246-20.2020.
    PubMed     Abstract available


  39. ZHANG H, Lin A, Gong P, Chen Y, et al
    The Chemokine-like Receptor 1 Deficiency Improves Cognitive Deficits of AD Mice and Attenuates Tau Hyperphosphorylation via Regulating Tau Seeding.
    J Neurosci. 2020;40:6991-7007.
    PubMed     Abstract available


    July 2020
  40. ZHANG H, Chen W, Tan Z, Zhang L, et al
    A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Abeta Clearance.
    J Neurosci. 2020;40:5347-5361.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: